298
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Attitude and willingness of attendance for participating in or completing acupuncture trials: a cross-sectional study

, , , , , , , & show all
Pages 53-61 | Published online: 24 Dec 2018

References

  • LiuJPAnalysis on the dependence and intention of experimental randomized controlled therapyZhongguo Zhong Xi Yi Jie He Za Zhi2003231288488614714353
  • WoodAMWhiteIRThompsonSGAre missing outcome data adequately handled? A review of published randomized controlled trials in major medical journalsClin Trials20041436837616279275
  • HaynesRBDantesRPatient compliance and the conduct and interpretation of therapeutic trialsControl Clin Trials19878112193568692
  • ZhouJJLiYZInvestigation and countermeasure research of patient complianceManagement of Traditional Chinese Medicine2013211111701172 Chinese
  • BostockSSteptoeAAssociation between low functional health literacy and mortality in older: a cross-sectional surveyBMJ2012344e160222422872
  • KayAHigginsJDayAGMeyerRMBoothCMRandomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end pointsAnn Oncol20122361646165122048151
  • BoothCMCesconDWWangLTannockIFKrzyzanowskaMKEvolution of the randomized controlled trial in oncology over three decadesJ Clin Oncol200826335458546418955452
  • JoffeSCookEFClearyPDClarkJWWeeksJCQuality of informed consent in cancer clinical trials: a cross-sectional surveyLancet200135892951772177711734235
  • GodskesenTHanssonMGNygrenPNordinKKihlbomUHope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trialsEur J Cancer Care2015241133141
  • DaughertyCRatainMJGrochowskiEPerceptions of cancer patients and their physicians involved in phase I trialsJ Clin Oncol1995135106210727738612
  • SchroenATPetroniGRWangHPreliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsClin Trials20107431232120595245
  • SchroenATPetroniGRWangHAchieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology GroupsClin Cancer Res201218125626221976533
  • StenslandKDMcbrideRWisniveskyJPPremature termination of genitourinary cancer clinical trialsJournal of Clinical Oncology2014324 suppl28824366930
  • ZhangHKThe status quo and changes of the education level of the elderly population in ChinaChinese Journal of Gerontology201636512151216
  • LiXLCaoHJZhangYJHuRXLiuJPCurrent status of missing data in domestic acupuncture clinical trial reports and its influence on research conclusionsJournal of Traditional Chinese Medicine2018597577581 Chinese
  • HollisSCampbellFWhat is meant by intention to treat analysis? Survey of published randomised controlled trialsBMJ1999319721167067410480822
  • GdLZhangLLCompliance management of the subjects in clinical drug trialsHosp Adm J Chin PLA2008153215217
  • LiYLiangFRZhaoLZhangLThe design, implementation, supervision and reporting of multi-centered acupunctural clinical trialZhongguo Zhong Xi Yi Jie He Za Zhi200929765265519852304
  • GfLInvestigation and analysis of the related factors of treatment compliance in patients with schizophreniaJ Nurs Train20122710926927
  • LnLWangYFqLInvestigation of depression and treatment compliance in elderly diabetic patientsJ Nurs Train2012272422332235
  • ShenAZChenFHChenLMResearch progress on patients’ complianceHerald Medicine2005248712714